Greenebaum Cancer Center, University of Maryland — Baltimore, Maryland

Greenebaum Cancer Center, University of Maryland is a clinical research site located in Baltimore, Maryland, United States 21201.

Crixeo Clinical Trials Trust Score: 83/100 (GOOD). This profile has not yet been claimed by the site owner.

Greenebaum Cancer Center, University of Maryland has participated in 4 clinical trials with 1 currently active.

Therapeutic areas: B-lymphoid Malignancies, Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma.

Sponsors: Sunesis Pharmaceuticals, Adaptimmune, Endocyte.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Baltimore

Browse all research sites in Maryland · View every site in Baltimore

Sponsor Feasibility Report

Trust Score: 83/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Greenebaum Cancer Center, University of Maryland?

Greenebaum Cancer Center, University of Maryland has a Crixeo Trust Score of 83/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Greenebaum Cancer Center, University of Maryland conducted?

Greenebaum Cancer Center, University of Maryland has 4 clinical trials on record, with 1 currently active. Their work covers B-lymphoid Malignancies, Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma.

Is Greenebaum Cancer Center, University of Maryland accredited by Crixeo Clinical Trials?

Greenebaum Cancer Center, University of Maryland has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Greenebaum Cancer Center, University of Maryland?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.